Black Diamond: Q4 Earnings Snapshot
By AP News
Published - Mar 12, 2024, 08:36 AM ET
Last Updated - Mar 12, 2024, 08:36 AM EDT
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Black Diamond Therapeutics, Inc. (BDTX) on Tuesday reported a loss of $19.4 million in its fourth quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 34 cents.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 47 cents per share.
For the year, the company reported that its loss narrowed to $82.4 million, or $1.88 per share.
